| Item Type | Name |
|
Concept
|
Birds
|
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Humans
|
|
Concept
|
Cryopreservation
|
|
Concept
|
Cell Movement
|
|
Concept
|
Dacarbazine
|
|
Concept
|
Hematopoietic Stem Cells
|
|
Concept
|
Comparative Genomic Hybridization
|
|
Concept
|
Escherichia coli
|
|
Concept
|
Hepatitis B Surface Antigens
|
|
Concept
|
Electrophoresis, Polyacrylamide Gel
|
|
Concept
|
Autoantibodies
|
|
Concept
|
Bacteriophage T4
|
|
Concept
|
Antibodies, Monoclonal
|
|
Concept
|
DNA Damage
|
|
Concept
|
Immunoglobulin Fragments
|
|
Concept
|
Lymphocyte Activation
|
|
Concept
|
Lipid A
|
|
Concept
|
Leukocytes, Mononuclear
|
|
Concept
|
Receptors, Tumor Necrosis Factor, Type I
|
|
Concept
|
Th1 Cells
|
|
Concept
|
Antigens, CD34
|
|
Concept
|
Fowlpox
|
|
Concept
|
Chromosomes, Human, Pair 3
|
|
Concept
|
Carcinoma, Renal Cell
|
|
Concept
|
Depression
|
|
Concept
|
Combined Modality Therapy
|
|
Concept
|
Antigens, Neoplasm
|
|
Concept
|
Aged
|
|
Concept
|
Insulin-Like Growth Factor I
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Antibodies
|
|
Concept
|
BCG Vaccine
|
|
Concept
|
Colorectal Neoplasms
|
|
Concept
|
Carcinoembryonic Antigen
|
|
Concept
|
Antibodies, Viral
|
|
Concept
|
Blotting, Western
|
|
Concept
|
T-Lymphocytes, Regulatory
|
|
Concept
|
Staphylococcal Protein A
|
|
Concept
|
Anti-Inflammatory Agents, Non-Steroidal
|
|
Concept
|
Luminescent Measurements
|
|
Concept
|
Myelodysplastic Syndromes
|
|
Concept
|
Antibodies, Neoplasm
|
|
Concept
|
Antineoplastic Agents, Phytogenic
|
|
Concept
|
Prostate-Specific Antigen
|
|
Concept
|
Clinical Protocols
|
|
Concept
|
Up-Regulation
|
|
Concept
|
Lymphocytes, Tumor-Infiltrating
|
|
Concept
|
Immunoprecipitation
|
|
Concept
|
Carcinogens
|
|
Concept
|
Mice
|
|
Concept
|
Bone Marrow Cells
|
|
Concept
|
Pyrroles
|
|
Concept
|
Cyclin-Dependent Kinase Inhibitor Proteins
|
|
Concept
|
Biopsy, Fine-Needle
|
|
Concept
|
Dinoprostone
|
|
Concept
|
Angiogenic Proteins
|
|
Concept
|
CD40 Ligand
|
|
Concept
|
Mice, Inbred C57BL
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Proto-Oncogene Proteins c-akt
|
|
Concept
|
Cyclin-Dependent Kinase Inhibitor p16
|
|
Concept
|
Avipoxvirus
|
|
Concept
|
Chemotherapy, Adjuvant
|
|
Concept
|
T-Lymphocytes
|
|
Concept
|
Multivariate Analysis
|
|
Concept
|
Lymphocyte Culture Test, Mixed
|
|
Concept
|
Antigens, CD
|
|
Concept
|
Signal Transduction
|
|
Concept
|
Monocytes
|
|
Concept
|
Biomedical Research
|
|
Concept
|
Immunoglobulin G
|
|
Concept
|
Receptor, Melanocortin, Type 1
|
|
Concept
|
Vascular Endothelial Growth Factor A
|
|
Concept
|
Enzyme-Linked Immunosorbent Assay
|
|
Concept
|
DNA Methylation
|
|
Concept
|
Apoptosis
|
|
Concept
|
Tumor Burden
|
|
Concept
|
Interleukin-10
|
|
Concept
|
Brain Neoplasms
|
|
Concept
|
Neoadjuvant Therapy
|
|
Concept
|
Diphtheria-Tetanus Vaccine
|
|
Concept
|
Flow Cytometry
|
|
Concept
|
Aged, 80 and over
|
|
Concept
|
Cell Division
|
|
Concept
|
Mice, Inbred CBA
|
|
Concept
|
Safety
|
|
Concept
|
Mice, Inbred BALB C
|
|
Concept
|
Imidazoles
|
|
Concept
|
Pyrazoles
|
|
Concept
|
CD8-Positive T-Lymphocytes
|
|
Concept
|
Fever
|
|
Concept
|
Lymphocyte Count
|
|
Concept
|
Disulfides
|
|
Concept
|
Biomarkers, Pharmacological
|
|
Concept
|
Monosomy
|
|
Concept
|
Antigen-Antibody Reactions
|
|
Concept
|
Antineoplastic Agents, Alkylating
|
|
Concept
|
Dependovirus
|
|
Concept
|
Emulsions
|
|
Concept
|
Diphtheria Toxin
|
|
Concept
|
Mice, Nude
|
|
Concept
|
Mice, SCID
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
CD4-Positive T-Lymphocytes
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Antimetabolites, Antineoplastic
|
|
Concept
|
Rats
|
|
Concept
|
beta 2-Microglobulin
|
|
Concept
|
Stress, Psychological
|
|
Concept
|
Benzamides
|
|
Concept
|
Interleukin-12
|
|
Concept
|
Chromosome Aberrations
|
|
Concept
|
Proteomics
|
|
Concept
|
Th2 Cells
|
|
Concept
|
Canarypox virus
|
|
Concept
|
Chromosome Deletion
|
|
Concept
|
Oligonucleotide Array Sequence Analysis
|
|
Concept
|
Middle Aged
|
|
Concept
|
Rats, Sprague-Dawley
|
|
Concept
|
MicroRNAs
|
|
Concept
|
Chemistry, Pharmaceutical
|
|
Concept
|
Young Adult
|
|
Concept
|
Promoter Regions, Genetic
|
|
Concept
|
Azacitidine
|
|
Concept
|
Base Sequence
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Tissue Array Analysis
|
|
Concept
|
Killer Cells, Natural
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Colonic Neoplasms
|
|
Concept
|
Vinblastine
|
|
Concept
|
Cytomegalovirus
|
|
Concept
|
Cell Line, Tumor
|
|
Concept
|
Insulin-Like Growth Factor Binding Protein 3
|
|
Concept
|
Phosphorylation
|
|
Academic Article
|
Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival.
|
|
Academic Article
|
Infusion of unpulsed dendritic cells derived from granulocyte/macrophage colony-stimulating factor-mobilized peripheral blood CD34+ cells and monocytes in patients with advanced carcinoma.
|
|
Academic Article
|
Genetically targeted adenovirus vector directed to CD40-expressing cells.
|
|
Academic Article
|
Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridge.
|
|
Academic Article
|
Immunization of colorectal cancer patients with recombinant baculovirus-derived KSA (Ep-CAM) formulated with monophosphoryl lipid A in liposomal emulsion, with and without granulocyte-macrophage colony-stimulating factor.
|
|
Academic Article
|
Enhanced gene transfer to mouse dendritic cells using adenoviral vectors coated with a novel adapter molecule.
|
|
Academic Article
|
Augmentation of antitumor activity of a recombinant adeno-associated virus carcinoembryonic antigen vaccine with plasmid adjuvant.
|
|
Academic Article
|
Antitumor activity of the intratumoral injection of fowlpox vectors expressing a triad of costimulatory molecules and granulocyte/macrophage colony stimulating factor in mesothelioma.
|
|
Academic Article
|
A DNA vaccine encoding genetic fusions of carcinoembryonic antigen (CEA) and granulocyte/macrophage colony-stimulating factor (GM-CSF).
|
|
Academic Article
|
Intratumoral administration of a recombinant canarypox virus expressing interleukin 12 in patients with metastatic melanoma.
|
|
Academic Article
|
High efficiency transduction of dendritic cells by adenoviral vectors targeted to DC-SIGN.
|
|
Academic Article
|
Phase I study of the intratumoral administration of recombinant canarypox viruses expressing B7.1 and interleukin 12 in patients with metastatic melanoma.
|
|
Academic Article
|
Phase I study of a plasmid DNA vaccine encoding MART-1 in patients with resected melanoma at risk for relapse.
|
|
Academic Article
|
Effect of docetaxel chemotherapy on the activity of a gonadotropin releasing hormone vaccine in patients with advanced prostate cancer.
|
|
Academic Article
|
Bisphosphonates inhibit the growth of mesothelioma cells in vitro and in vivo.
|
|
Academic Article
|
Anti-GD3 monoclonal antibody effects on lymphocytes and antibody-dependent cellular cytotoxicity.
|
|
Academic Article
|
A phase I study of an anti-GD3 monoclonal antibody, KW-2871, in patients with metastatic melanoma.
|
|
Academic Article
|
Targeted therapy for uveal melanoma.
|
|
Academic Article
|
Clinical and biological effects of neoadjuvant sargramostim and thalidomide in patients with locally advanced prostate carcinoma.
|
|
Academic Article
|
Differential effects of imatinib mesylate against uveal melanoma in vitro and in vivo.
|
|
Academic Article
|
A phase I study of sunitinib plus bevacizumab in advanced solid tumors.
|
|
Academic Article
|
Effects of interleukin-1 receptor antagonist and chemotherapy on host-tumor interactions in established melanoma.
|
|
Academic Article
|
Clinical and immunomodulatory effects of bevacizumab and low-dose interleukin-2 in patients with metastatic renal cell carcinoma: results from a phase II trial.
|
|
Academic Article
|
Regulation of the activity of an adeno-associated virus vector cancer vaccine administered with synthetic Toll-like receptor agonists.
|
|
Academic Article
|
Circulating tumor cells in uveal melanoma.
|
|
Academic Article
|
Noncytotoxic differentiation treatment of renal cell cancer.
|
|
Academic Article
|
Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo.
|
|
Academic Article
|
VB-111 for cancer.
|
|
Academic Article
|
Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects.
|
|
Academic Article
|
p53-Independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies.
|
|
Academic Article
|
Differential effects of low-dose decitabine on immune effector and suppressor responses in melanoma-bearing mice.
|
|
Academic Article
|
Blood biomarkers for uveal melanoma.
|
|
Academic Article
|
Differential immunologic and microRNA effects of 2 dosing regimens of recombinant human granulocyte/macrophage colony stimulating factor.
|
|
Academic Article
|
Elevated blood ß-2 microglobulin is associated with tumor monosomy-3 in patients with primary uveal melanoma.
|
|
Academic Article
|
The association of blood angioregulatory microRNA levels with circulating endothelial cells and angiogenic proteins in patients receiving dacarbazine and interferon.
|
|
Academic Article
|
Sargramostim (GM-CSF) and lenalidomide in castration-resistant prostate cancer (CRPC): results from a phase I-II clinical trial.
|
|
Academic Article
|
Phase I dose-escalation study of VB-111, an antiangiogenic virotherapy, in patients with advanced solid tumors.
|
|
Academic Article
|
Circulating melanoma cells: scoping the target.
|
|
Academic Article
|
Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease.
|
|
Academic Article
|
Enrichment of circulating melanoma cells (CMCs) using negative selection from patients with metastatic melanoma.
|
|
Academic Article
|
Dual VEGF/VEGFR inhibition in advanced solid malignancies: clinical effects and pharmacodynamic biomarkers.
|
|
Academic Article
|
Genomic microarray analysis on formalin-fixed paraffin-embedded material for uveal melanoma prognostication.
|
|
Academic Article
|
Biology of advanced uveal melanoma and next steps for clinical therapeutics.
|
|
Academic Article
|
iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors.
|
|
Academic Article
|
Spontaneous cellular and humoral tumor antigen responses in patients with uveal melanoma.
|
|
Academic Article
|
Depression, Anxiety, and Regret Before and After Testing to Estimate Uveal Melanoma Prognosis.
|
|
Academic Article
|
Fine-needle aspiration biopsy of uveal melanoma: outcomes and complications.
|
|
Academic Article
|
Association of tumor and plasma microRNA expression with tumor monosomy-3 in patients with uveal melanoma.
|
|
Academic Article
|
Expression of natural killer cell regulatory microRNA by uveal melanoma cancer stem cells.
|
|
Grant
|
Intratumoral Dendritic Cells Plus Interleukin-2
|
|
Grant
|
AAV-Based Plasmacytoid Dendritic Cell Cancer Vaccine
|
|
Grant
|
ANTIGEN PULSED DENDRITIC CELL IMMUNOTHERAPY
|
|
Grant
|
Uveal Melanoma Micrometastasis
|
|
Academic Article
|
Survival and Failure Outcomes Predicted by Brain Metastasis Volumetric Kinetics in Melanoma Patients Following Upfront Treatment with Stereotactic Radiosurgery Alone.
|
|
Academic Article
|
Practical Guidelines for Cerenkov Luminescence Imaging with Clinically Relevant Isotopes.
|
|
Academic Article
|
Tumor mutational burden is a determinant of immune-mediated survival in breast cancer.
|
|
Academic Article
|
Circulating immune biomarkers as predictors of the response to pembrolizumab and weekly low dose carboplatin and paclitaxel in NSCLC and poor PS: An interim analysis.
|
|
Academic Article
|
Melanocortin 1 Receptor-Targeted a-Particle Therapy for Metastatic Uveal Melanoma.
|
|
Academic Article
|
A prospective trial of adjuvant therapy for high-risk uveal melanoma: assessing 5-year survival outcomes.
|